Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 14
2021 23
2022 16
2023 13
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study.
Colaneri M, Genovese C, Fassio F, Canuti M, Giacomelli A, Ridolfo AL, Asperges E, Albi G, Bruno R, Antinori S, Muscatello A, Mariani B, Canetta C, Blasi F, Bandera A, Gori A. Colaneri M, et al. Infect Dis Ther. 2024 Apr 21. doi: 10.1007/s40121-024-00967-6. Online ahead of print. Infect Dis Ther. 2024. PMID: 38643431
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.
Colaneri M, Scaglione G, Fassio F, Galli L, Lai A, Bergna A, Gabrieli A, Tarkowski M, Ventura CD, Colombo V, Cordier L, Bernasconi D, Corbellino M, Dedivitiis G, Borghetti S, Visigalli D, Sollima S, Casalini G, Rizzardini G, Gori A, Antinori S, Riva A, Schiavini M. Colaneri M, et al. Virol J. 2024 Mar 20;21(1):68. doi: 10.1186/s12985-024-02333-x. Virol J. 2024. PMID: 38509536 Free PMC article.
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death.
Minnai F, Biscarini F, Esposito M, Dragani TA, Bujanda L, Rahmouni S, Alarcón-Riquelme ME, Bernardo D, Carnero-Montoro E, Buti M, Zeberg H, Asselta R, Romero-Gómez M; GEN-COVID Multicenter Study; Fernandez-Cadenas I, Fallerini C, Zguro K, Croci S, Baldassarri M, Bruttini M, Furini S, Renieri A, Colombo F. Minnai F, et al. Sci Rep. 2024 Feb 6;14(1):3000. doi: 10.1038/s41598-024-53310-x. Sci Rep. 2024. PMID: 38321133 Free PMC article.
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy.
Lombardi A, Villa S, Colaneri M, Scaglione G, Bai F, Varisco B, Bono V, Vena A, Dentone C, Russo C, Tettamanti M, Renisi G, Viero G, Azzarà C, Mantero M, Peyvandi F, Bassetti M, Marchetti G, Muscatello A, Nobili A, Gori A, Bandera A; “COVID 19 NETWORK”. Lombardi A, et al. Among authors: colaneri m. J Infect Public Health. 2024 Mar;17(3):467-473. doi: 10.1016/j.jiph.2023.12.026. Epub 2024 Jan 17. J Infect Public Health. 2024. PMID: 38262085 Free article.
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience.
Cattaneo D, Fusi M, Colaneri M, Fusetti C, Genovese C, Giorgi R, Matone M, Merli S, Petri F, Gori A. Cattaneo D, et al. Among authors: colaneri m. Antibiotics (Basel). 2023 Dec 24;13(1):20. doi: 10.3390/antibiotics13010020. Antibiotics (Basel). 2023. PMID: 38247579 Free PMC article.
66 results